Company news
PYC Therapeutics Limited news in 2016
PYC Therapeutics Limited's news releases, calls and decks from 2016, newest first.
Grant for Cancer Drug Research
February 10, 2016
Fully Underwritten Renouncable Rights Issue
February 10, 2016
FNN interview N Woolf Pfizer Deal, Goals for 2011
February 10, 2016
Europe Patent Phenotypic Screening
February 10, 2016
European Patent Synthetic Phylomers
February 10, 2016
Entitlement Issue Supplementary Prospectus
February 10, 2016
Entitlement Issue Prospectus
February 10, 2016
Entitlement Issue Offer Document
February 10, 2016
Entitlement Issue
February 10, 2016
Converting Note Placement
February 10, 2016
Collaboration with PEPSCAN
February 10, 2016
Collaboration to Commercialise Anti Inflammatory Phylomers
February 10, 2016
CEO and Director Changes
February 10, 2016
Cancer pilot study success
February 10, 2016
Australian Research Council Grant
February 10, 2016
Appendix 4E and Audited Annual Financial Statements
February 10, 2016
Animal model cancer studies
February 10, 2016
Agreement with Major UK company to Build New Drugs
February 10, 2016
Decks in 2016
- Phylogica — Shareholder Meeting (November 2016)
Shareholder meeting · 27 slides · Nov 25, 2016
- Phylogica — BIO 2016
Conference · 33 slides · Jun 7, 2016
- Phylogica — Broker Meets Biotech, Perth (March 2016)
Conference · 21 slides · Apr 1, 2016